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Abstract
Background: Fracture represents the single most important clinical event in patients with osteoporosis, yet
remains under-predicted. As few premonitory symptoms for fracture exist, it is of critical importance that
physicians effectively and efficiently identify individuals at increased fracture risk.
Methods: Of 3426 postmenopausal women in CANDOO, 40, 158, 99, and 64 women developed a new hip,
vertebral, wrist or rib fracture, respectively. Seven easily measured risk factors predictive of fracture in research
trials were examined in clinical practice including: age (<65, 65–69, 70–74, 75–79, 80+ years), rising from a chair
with arms (yes, no), weight (< 57, ≥ 57kg), maternal history of hip facture (yes, no), prior fracture after age 50
(yes, no), hip T-score (>-1, -1 to >-2.5, ≤-2.5), and current smoking status (yes, no). Multivariable logistic
regression analysis was conducted.
Results: The inability to rise from a chair without the use of arms (3.58; 95% CI: 1.17, 10.93) was the most
significant risk factor for new hip fracture. Notable risk factors for predicting new vertebral fractures were: low
body weight (1.57; 95% CI: 1.04, 2.37), current smoking (1.95; 95% CI: 1.20, 3.18) and age between 75–79 years
(1.96; 95% CI: 1.10, 3.51). New wrist fractures were significantly identified by low body weight (1.71, 95% CI: 1.01,
2.90) and prior fracture after 50 years (1.96; 95% CI: 1.19, 3.22). Predictors of new rib fractures include a maternal
history of a hip facture (2.89; 95% CI: 1.04, 8.08) and a prior fracture after 50 years (2.16; 95% CI: 1.20, 3.87).
Conclusion: This study has shown that there exists a variety of predictors of future fracture, besides BMD, that
can be easily assessed by a physician. The significance of each variable depends on the site of incident fracture. Of
greatest interest is that an inability to rise from a chair is perhaps the most readily identifiable significant risk factor
for hip fracture and can be easily incorporated into routine clinical practice.
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Background
Osteoporosis affects one in four women and one in eight
men in Canada [1]. Its consequences are devastating both
to the individual and society in terms of suffering, disabil-
ity, and increased health care expenses. It is expected that
over the next 40 years the number of hip fractures alone
will increase exponentially, leading to a problem of epi-
demic proportions [2]. Fragility fractures are the most
important and disabling consequence of osteoporosis and
result in a loss of functional ability and increased morbid-
ity and mortality. Estimated conservatively, a 50 year old
woman has a 40 percent lifetime risk of a hip, vertebral or
wrist fracture [3]. In 1993, the Canadian health care sys-
tem spent more than $1.3 billion on osteoporosis-related
fractures [4]. Recent research has shown that the mean
one-year cost of a hip fracture, including direct and indi-
rect costs, is (CAN) $26 527 [5].
Predicting incident fractures is critical today, but in light
of the aging demographics, will have even greater impor-
tance in the future. Early recognition and treatment of
osteoporotic patients is crucial to the prevention of these
fractures. A number of risk factors have come to define
those at increased risk for osteoporotic fracture and much
work has been done in an attempt to delineate the critical
variables [6-11]. In order for risk assessment to be effec-
tive and efficient, it must be practical and have high pre-
dictive value for the identification of fractures. Black et al.,
with use of data from the Study of Osteoporotic Fractures
(SOF), developed the Fracture Index [12]. This assessment
tool for predicting fracture risk in osteoporotic post-men-
opausal women was shown to be predictive of incident
osteoporotic fractures (hip, vertebral, wrist and rib) in
post-menopausal women and was validated using the
EPIDOS study [12]. The Fracture Index assessment tool
considers seven variables: age, fracture after age 50, his-
tory of maternal hip fracture after age 50, weight less than
125 lb (57 kg), smoking status, use of arms to stand up
from a chair and bone mineral density (BMD) T-score
[12]. These variables were chosen not only based on their
predictive value but also because of their ease of assess-
ment in a clinical setting. As a result, we sought to exam-
ine the usefulness of these risk factors in a clinical
specialist setting.
The purpose of this study was to examine whether the risk
factors outlined in the Fracture Index could be used to pre-
dict new incident osteoporotic fractures of the hip, verte-
bra, wrist, and rib in postmenopausal women who are
registered in The Canadian Database for Osteoporosis and
Osteopenia (CANDOO).
Methods
Study design
An analysis using prospective collected patient informa-
tion from the CANDOO database was conducted. The
CANDOO registry is a multi-site (Calgary, Winnipeg, Sas-
katoon, Toronto, Hamilton, Montreal, Quebec City) data-
base consisting of more than 10,000 men and women
who have been referred to specialists for osteoporosis
[13]. The CANDOO database is designed to gather oste-
oporosis-related clinical information in a prospective
manner displaying a record at each clinical visit. Patient
information is entered and recorded into a central data-
base [13]. It includes information on patient demograph-
ics; vertebral, rib, wrist and hip fracture history;
gynecological history; use of osteoporosis related drugs;
drug side effects; use of corticosteroids and other medica-
tions; dietary calcium intake; smoking habits; physical
activity; fall history; prior medical history; family history
including fractures; a self administered osteoporosis
health related quality of life instrument; basic laboratory
results and bone density measurements [13]. Patients
were followed yearly with detailed assessments at clinical
centres. Each yearly visit involved the collection of infor-
mation similar to that collected at baseline.
All centres with a baseline CANDOO assessment (visit 1)
between 1990 and 1999 with follow-up data available
were selected. Only postmenopausal women ≥ 55 years of
age with follow-up data available entered in CANDOO
were considered for inclusion. Individuals with no follow-
up assessments or males were excluded. Any individuals
experiencing multiple fractures were also excluded in
order to group subjects into hip, vertebral, wrist or rib
fracture groups respectively. This exclusion criteria limited
the number of applicable subjects from CANDOO and
simultaneously implicated only females in the analysis.
Fractures in CANDOO were determined based on either
self-reports or X-ray confirmation.
For the current study we examined the seven easily meas-
ured clinical risk factors for fracture outlined in the Frac-
ture Index. Each risk factor was expressed as an
independent variable. The major dichotomous risk factors
abstracted were: vertebral, rib, wrist or hip fractures after
age 50 (yes/no); maternal family history of fracture (yes/
no); weight < 57 kg (≤ 57 kg, > 57 kg); smoking status
(yes/no); use of arms to stand from seated position (yes/
no). Non-dichotomous risk factors abstracted included:
age (<65, 65–69, 70–74, 75–79, 80–84, 85+ years); bone
mineral density total hip T-score (> -1, -1 to -2.5, ≤ -2.5)
(measurements were made using dual energy X-ray
absorptiometry using Lunar or Hologic densitometers)
[13]. Adjustments for osteoporotic drug treatment and
inclusion of the osteoporosis quality of life questionnaire
(OQLQ) as a variable were considered.BMC Musculoskeletal Disorders 2005, 6:47 http://www.biomedcentral.com/1471-2474/6/47
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Statistical analysis
Using the seven independent variables we conducted mul-
tivariate logistic regression analyses for each fracture type
to identify which of the seven risk factors were related to
fracture in patients from the CANDOO database.
While longitudinal databases are a powerful research tool,
a common weakness is that of missing or incomplete data.
To minimize the bias associated with missing data, multi-
ple imputation was utilized to replace missing data prior
to the analyses [14,15]. In this case, 10 complete data sets
were generated. The multiple imputed datasets were then
analyzed using standard procedures for complete data
and the results were pooled. Odds ratios and the associ-
ated 95% confidence intervals were calculated.
Results
Baseline characteristics
A total of 3426 patients were evaluated. Of those patients
examined, 99 developed a wrist fracture, 64 a rib fracture,
158 a vertebral fracture, 40 a new hip fracture and 3065
experienced no fracture. Individuals in CANDOO who
developed multiple fractures, 53 in total, were excluded
from the analyses. The mean age and weight of the
patients was 68 years and 64 kg, respectively. Mean total
hip T-score was -1.9.
Baseline characteristics for the risk factors examined are
displayed in Table 1. More than one third (36.8 %) of the
women included were <65 years of age. While many sub-
jects did not have a BMD assessment, 54.8 % of those that
did had a T-score between -1 and -2.5. Only 5.6 % of post-
menopausal women in CANDOO reported having a
maternal history of hip fracture while 41.2 % had a prior
fracture after the age of 50 years and 10.5 % were current
smokers. Of the entire group, approximately half were
only able to rise from a chair with the use of arms (as com-
pared with no arms) and 30.2 % of patients weighed less
the 57 kg.
Hip fractures
The results of multivariable logistic regression analyses for
each of the seven risk factors examined to predict a new
fracture event in the hip are presented in Table 2. Prior
fracture after the age of 50 years, those currently smoking,
those between 75–79 years of age and those with a T-score
of < -2.5 indicated a trend towards higher risk of develop-
ing a new hip fracture. The one factor that was statistically
significant for predicting subsequent hip fractures were
those individuals only able to rise from a chair with the
aid of their arms. These individuals had an approximate
odds ratio of 3.6. The 95% confidence interval of each risk
factor predicting higher risk of developing a new fracture
at the hip site is shown in Figure 1. All the factors had
fairly wide confidence intervals, in part due to the overall
low incidence of hip fractures. Maternal history of hip
fracture was excluded from this model as the hip fracture
group contained no data on maternal history of hip
fracture.
Vertebral fractures
The results of multivariate logistic regression analyses for
each of the seven risk factors thought to predict a new ver-
tebral fracture within the CANDOO database are depicted
in Figure 2 and Table 3. Of all the risk factors, three were
found to be significant predictors of new spinal fractures.
Current smokers and those between the ages of 75–79
years were approximately two times more likely to
develop a new vertebral fracture. Individuals weighing less
than 57 kg were about 1.6 times more likely to develop a
new fracture at this site. The other four risk factors did not
reach statistical significance in terms of their predictability
of a new fracture at vertebral sites in CANDOO.
Wrist fractures
Table 4 shows odds ratios and 95% confidence intervals
for each risk factor for fractures at the wrist. Each of the
seven risk factors' independent ability to predict a new
wrist fracture is illustrated in Figure 3. Prior fracture after
the age of 50 and a body weight less than 57 kg were
deemed significant risk factors for a new incident wrist
fracture. Individuals with a prior fracture after the age of
50 years and those weighing less than 57 kg were about
two and 1.7 times more likely to develop a new wrist frac-
ture, respectively. The other five risk factors were not sta-
tistically significant.
Rib fractures
Individuals with a maternal history of a hip fracture and a
prior fracture after the age of 50 years were approximately
Table 1: Baseline characteristics of risk factors for patient 
cohort.
RISK FACTOR n (% of cohort)
Age < 64.5 years 1259 (36.8)
Age 64.5–69.5 740 (21.6)
Age 69.5–74.5 751 (21.9)
Age 74.5–79.5 426 (12.4)
Age 79.5–84.5 186 (5.4)
Age ≥ 84.5 64 (1.9)
Total Hip T-score, T > -1 89 (19.9)
Total Hip T-score, -2.5<T<-1 245 (54.8)
Total Hip T-score, T ≤ -2.5 113 (25.3)
Maternal history of hip fracture 192 (5.6)
Prior fracture >50 years 1413 (41.2)
Current smokers 361 (10.5)
Rise from a chair with arms 1242 (49.2)
Weight < 57 kg 867 (30.2)BMC Musculoskeletal Disorders 2005, 6:47 http://www.biomedcentral.com/1471-2474/6/47
Page 4 of 9
(page number not for citation purposes)
three and two times more likely, respectively, to develop a
new rib fracture during the course of the study. Those with
any of the other five risk factors were not at significantly
increased risk of sustaining a new fracture at the rib. These
data are displayed in Table 5 and Figure 4.
Discussion
Even with the advent of the recent publication of the 2002
Osteoporosis Society of Canada's Clinical Practice Guide-
lines, there remains no universal way of identifying those
with osteoporosis and those at increased risk of fracture.
The clinical goal must be to identify the substantial per-
centage of the population at high risk for fracture while
simultaneously limiting any unnecessary testing to the
increasingly burdened health care system [16,17]. Preven-
tion of an incident fracture and the cascade of subsequent
fractures is the ultimate objective.
We found a variety of clinical risk factors in conjunction
with BMD to be extremely helpful in distinguishing those
at high risk of fracture in CANDOO.
The association of increasing age with declining bone
density has long been recognized as being the predomi-
nant risk factor for fracture. Age was shown to be an inde-
pendent predictor of hip fracture in the EPIDOS study [6].
For ages 45 through 85, the ten year probability of a frac-
ture in the forearm, humerus, spine or hip increases five
Table 2: Hip Fracture Results Odds ratios and 95% confidence intervals point estimates for each risk factor in the development of new 
hip fracture
RISK FACTOR Odds Ratio 95% Confidence Interval
Weight (< 57 Kg) *Reference Level: ≥ 57 Kg 1.70 0.719; 4.037
Use of Arms to Rise *Reference Level: rise without arms 3.58 1.173; 10.927
Smoking Status *Reference Level: no smoking 1.48 0.485; 4.536
Age (65 to 69 y) *Reference Level: < 65 1.53 0.505; 4.667
Age (70–74 y) *Reference Level: < 65 0.98 0.280; 3.421
Age (75–79 y) *Reference Level: < 65 1.62 0.451; 5.840
Age (80–84 y) *Reference Level: < 65 1.52 0.296; 7.780
Age (85+y) *Reference Level: < 65 4.36 0.823; 23.078
Previous Fracture After 50 y
*Reference Level: no fracture after 50
1.08 0.477; 2.463
Osteoporotic (<-2.5 SD)**
*Reference Level: normal BMD
1.69 0.233; 12.253
Odds ratios and confidence intervals for each risk factor that  predicts higher risk of hip fracture Figure 1
Odds ratios and confidence intervals for each risk factor that 
predicts higher risk of hip fracture.
Odds ratios and confidence intervals for each risk factor that  predicts higher risk of vertebral fracture Figure 2
Odds ratios and confidence intervals for each risk factor that 
predicts higher risk of vertebral fracture.BMC Musculoskeletal Disorders 2005, 6:47 http://www.biomedcentral.com/1471-2474/6/47
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times in men and eight times in women [18]. It has been
estimated by Kanis et al. that risk of fracture in the forearm
alone can increase eight times between the ages of 45 and
85 [18]. The results from the CANDOO database showed
that although age, especially between 75 to 79 years, was
associated with heightened risk of fracture at all sites, it
only reached significance for predicting future fractures at
vertebral sites. These results indicate that it is possible that
age alone may not be definitive in predicting overall frac-
ture risk.
In a clinical setting, BMD remains the gold-standard in
assessing fracture risk so long as it is considered within the
context of age. Cummings et al. showed that for each
standard deviation decline in femoral neck BMD is associ-
ated with 2.6 times the risk of hip fracture in
postmenopausal women aged 65 years or more [19].
Although BMD can identify people who are at increased
risk of experiencing a fracture, it cannot, with any cer-
tainty, identify those individuals who will necessarily sus-
tain a future fracture. Moreover, BMD testing is both
inconvenient and expensive. Many under-serviced areas
do not have the technology available for assessing BMD
and even in those areas where machines are available,
such procedures may be difficult to access due to mobility
issues for osteoporotic patients and elderly subjects in
long-term care facilities. Results from the CANDOO data-
base did not indicate the overwhelming importance of
BMD values in predicting those at increased fracture risk
at any of the four sites considered. While a clinically rele-
vant association was seen between BMD and fracture, its
association was not statistically significant. This could at
least in part arise from the small number of eligible sub-
jects in CANDOO with BMD assessments.
Previous fracture history is well known to be predictive of
future fracture risk [10,20-23]. The number of prior frac-
tures at the site of incident fracture (i.e. hip, spine) com-
bined with age has been shown to increase fracture risk
1.5 to 9.5 times [10,20,21,23-27]. Prior fracture at verte-
bral sites increases the risk of future fracture by as much as
four times [28,29]. A previous history of fracture repre-
sented an important factor in evaluating the risk of future
non-vertebral (wrist and rib) fractures in the CANDOO
patients. At hip related sites within the CANDOO popula-
tion, previous fracture history was not significant in
Table 3: Vertebral Fracture Results Odds ratios and 95% confidence intervals point estimates for each risk factor in the development 
of a new vertebral fracture
RISK FACTOR Odds Ratio 95% Confidence Interval
Weight (< 57 Kg) *Reference Level: ≥ 57 Kg 1.57 1.035; 2.373
Use of Arms to Rise *Reference Level: rise without arms 1.72 0.981; 3.023
Smoking Status *Reference Level: no smoking 1.95 1.199; 3.184
Age (65 to 69 y) *Reference Level: < 65 1.36 0.805; 2.309
Age (70–74 y) *Reference Level: < 65 1.28 0.753; 2.174
Age (75–79 y) *Reference Level: < 65 1.96 1.096; 3.508
Age (80–84 y) *Reference Level: < 65 0.93 0.368; 2.334
Age (85+y) *Reference Level: < 65 1.32 0.375; 4.631
Previous Fracture After 50 y
*Reference Level: no fracture after 50
1.37 0.931; 2.012
Maternal History of Fracture
*Reference Level: no family history
0.85 0.296; 2.412
Osteoporotic (<-2.5 SD)**
*Reference Level: normal BMD
1.85 0.448; 7.676
Odds ratios and confidence intervals for each risk factor that  predicts higher risk of wrist fracture Figure 3
Odds ratios and confidence intervals for each risk factor that 
predicts higher risk of wrist fracture.BMC Musculoskeletal Disorders 2005, 6:47 http://www.biomedcentral.com/1471-2474/6/47
Page 6 of 9
(page number not for citation purposes)
predicting future hip fracture risk. This may be explained
by the low incidence of hip fractures and the fact that
many vertebral fractures remain undiagnosed. In fact, it
has been estimated that less than one third of all vertebral
fractures are clinically diagnosed [30].
Much evidence has indicated that those with a maternal
history of fracture, especially at the hip, are at increased
risk of future fracture. Moreover, those whose maternal
history involves a grandmother, carry an even greater risk
of hip fracture [11]. Within the CANDOO patients, the
predictive ability of this variable appeared to be less
important. At all sites, with the exception of the rib,
maternal family history of fracture showed no significant
association with increased fracture risk. This could possi-
bly be explained by poor recollection or documentation
of maternal history within the baseline assessment.
Low body weight was shown to be a significant predictor
of future fracture at both vertebral and wrist sites. It played
a significant role in assessing fracture risk at these sites,
but appeared to be less important in determining risk of
future fracture in the hip or rib.
The direct effects of smoking resulting in declining BMD
and increased fracture risk have been identified by a vari-
ety of different studies [31-34]. Individuals who reported
smoking in CANDOO were only at significantly increased
risk of fracture at vertebral sites. These results indicate that
at least in CANDOO, smoking as a risk factor is limited at
other sites.
Many risk factors incorporated into the Fracture Index and
other publications focus on biological, historical or BMD-
affecting variables in risk factor analysis. Although the
importance of these particular risk factors is unquestiona-
ble, a considerable number of osteoporotic fractures result
from falls. Easily assessed neuromuscular measures of fall-
related hip fracture have been examined in a few studies
[10,35,36]. With the use of data from EPIDOS, Dargent-
Molina et al. found that four predictors of fall-related frac-
ture (slow gait speed, difficulty in tandem walking,
reduced visual acuity, small calf circumference) were sig-
nificantly associated with increased risk of future hip frac-
ture [35]. A similar study confirmed that a simple and
Table 4: Wrist Fracture Results Odds ratios and 95% confidence intervals point estimates for each risk factor in the development of a 
new fracture at the wrist
RISK FACTOR Odds Ratio 95% Confidence Interval
Weight (< 57 Kg) *Reference Level: ≥ 57 Kg 1.71 1.007; 2.897
Use of Arms to Rise *Reference Level: rise without arms 1.53 0.790; 2.981
Smoking Status *Reference Level: no smoking 0.62 0.259; 1.466
Age (65 to 69 y) *Reference Level: < 65 0.76 0.387; 1.485
Age (70–74 y) *Reference Level: < 65 1.00 0.539; 1.843
Age (75–79 y) *Reference Level: < 65 0.57 0.238; 1.387
Age (80–84 y) *Reference Level: < 65 0.46 0.134; 1.603
Age (85+y) *Reference Level: < 65 0.83 0.183; 3.776
Previous Fracture After 50 y
*Reference Level: no fracture after 50
1.96 1.191; 3.223
Maternal History of Fracture
*Reference Level: no family history
1.25 0.430; 3.627
Osteoporotic (<-2.5 SD)**
*Reference Level: normal BMD
2.26 0.476; 10.682
Odds ratios and confidence intervals for each risk factor that  predicts higher risk rib fracture Figure 4
Odds ratios and confidence intervals for each risk factor that 
predicts higher risk rib fracture.BMC Musculoskeletal Disorders 2005, 6:47 http://www.biomedcentral.com/1471-2474/6/47
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efficient measure of gait speed had the same discriminant
value for fracture prediction as femoral BMD at all cutoff
values [36]. It was the prospective study by Cummings et
al. [10] that indicated the importance of examining one's
ability to rise from a chair without the use of arms in risk
assessment. They determined that this factor alone was
the most significant at predicting hip fracture and that the
addition of other neuromuscular assessment tests added
little to the prediction of subsequent hip fracture [10].
The use of arms to rise from a seated position was found
to be the single most important predictor of increased
fracture risk at the hip in CANDOO patients. These results
indicate that both research and clinical settings should
place a greater emphasis than is currently standard proce-
dure on this variable or others that examine neuromuscu-
lar ability. Such an easily assessed risk factor would make
for an efficient and effective mechanism to gauge risk
across the entire population, especially in those for which
BMD testing is not feasible.
Many of these risk factors have been successfully incorpo-
rated into clinical risk assessment tools, while others such
as the use of arms to rise from a chair tend to be ignored.
A variety of current risk assessment mechanisms are used
routinely in clinical practice, including the Osteoporosis
Risk Assessment Instrument (ORAI), Simple Calculated
Osteoporosis Risk Estimation (SCORE) and the module
Physicians' Information and Education Resource (PIER)
[37-39].
The ORAI is a clinical assessment tool that was designed
to identify women over the age of 45 who are at increased
risk for osteoporosis who should undergo BMD testing.
This simple tool uses three items (age, weight and estro-
gen use) to gauge risk and has been validated to identify
over 90% of women at increased risk of osteoporotic frac-
ture while ensuring that less than 50 % of those with
normal BMD are selected [37]. Although this procedure
has proven to be useful in clinically identifying patients at
risk, it only allows for examination of females and relies
completely on historical risk factors.
A similar mechanism for identifying individuals at
increased risk in clinical practice was set forth in SCORE.
This tool relies on six risk factors rather than three in order
to assess risk of osteoporotic fracture. These six variables
include: race, age, rheumatoid arthritis, history of non-
traumatic fracture after age 45, weight and estrogen use
[37]. Despite its incorporation of more risk factors,
SCORE has been shown to have similar sensitivity to
ORAI but greater selection of individuals with normal
BMD [40].
The effectiveness of determining those individuals at
increased risk of future fracture not only revolves around
public awareness of risk factors, but relies heavily on the
ability of physicians (especially in primary care settings)
to effectively and efficiently identify at-risk individuals.
Module PIER [39] is a web and computer based resource
designed to guide physicians through the diagnosis, treat-
ment and management of a plethora of diseases including
osteoporosis. Their recommendations include the use of
the Fracture Index for risk assessment and analyses of
other variables including use of corticosteroid therapy for
more than 3 months, impaired vision, low calcium intake,
low physical activity, dementia, alcohol consumption of
greater than 2 drinks per day and estrogen deficiency
before 45 years of age. Subsequently, any post-menopau-
sal woman over 65 years of age or those under 65 who
Table 5: Rib Fracture Results Odds ratios and 95% confidence intervals point estimates for each risk factor in the development of a 
new fracture at the rib
RISK FACTOR Odds Ratio 95% Confidence Interval
Weight (< 57 Kg) *Reference Level: ≥ 57 Kg 0.47 0.222; 1.011
Use of Arms to Rise *Reference Level: rise without arms 1.93 0.868; 4.272
Smoking Status *Reference Level: no smoking 1.94 0.903; 4.179
Age (65 to 69 y) *Reference Level: < 65 1.42 0.631; 3.210
Age (70–74 y) *Reference Level: < 65 1.58 0.709; 3.516
Age (75–79 y) *Reference Level: < 65 2.26 0.928; 5.486
Age (80–84 y) *Reference Level: < 65 2.69 0.950; 7.625
Age (85+y) *Reference Level: < 65 1.04 0.126; 8.478
Previous Fracture After 50 y
*Reference Level: no fracture after 50
2.16 1.201; 3.874
Maternal History of Fracture
*Reference Level: no family history
2.89 1.035; 8.081
Osteoporotic (<-2.5 SD)**
*Reference Level: normal BMD
3.89 0.367; 41.263BMC Musculoskeletal Disorders 2005, 6:47 http://www.biomedcentral.com/1471-2474/6/47
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have at least one of these risk factors is recommended to
have her BMD assessed. The inclusion of risk factors to
assess frailty and mobility in PIER, such as the use of arms
to rise from a chair and impaired vision, takes into consid-
eration the importance of preventing falls and future frac-
ture rather than solely basing risk assessment on historical
risk factors.
Our study incorporated a large sample of post-menopau-
sal women from the CANDOO database. The subject data
from this database were homogeneous as they stemmed
from a group of patients who were assessed in the tertiary
care setting and represented a "real world" group [13].
Moreover, the multivariable analyses involved detailed
and controlled delineation of potential confounding
variables.
Although the study design attempted to minimize limit-
ing factors, it should be recognized that much of the infor-
mation in the CANDOO database relied on factual recall
from patients, some of which was reviewed at considera-
ble length after the experience had occurred. In addition,
although careful delineation of confounding variables
was carried out, it remains uniquely possible that other
potential confounders played a role. Assessment of frac-
tures for the CANDOO database were either confirmed or
self-reported and as a result sub-clinical fractures in
patients could have been missed. Also, the lack of data on
male patients meant only females were assessed and, as
such, results should not necessarily be extrapolated to the
male population.
Further studies will need to be undertaken in attempt to
identify a more definitive and indicative group of risk fac-
tors that can be used across genders and populations to
assess future fracture risk and the subsequent develop-
ment of osteoporosis.
Conclusion
Despite extensive research and new treatment strategies,
osteoporosis remains one of the "sleeping giants of health
care". Much of the population remains undiagnosed and
unaware of the importance of early recognition and pre-
ventative treatment. As the "boomer bulge" continues to
progress through middle age and into senior brackets, the
effects of osteoporosis on both the individual and health
care system will be enormous. This study has shown that
there exists a variety of predictors of future fracture,
besides BMD, that can be easily assessed by a physician.
The predictive significance of each of these risk factors has
been shown to be dependent on the site of incident frac-
ture. The assessment of unconventional risk factors such
as examining one's ability to rise from a chair without the
use of arms to gauge proprioception, strength and coordi-
nation are simple, convenient and valuable in terms of
predicting fracture risk. These risk assessment factors can
be easily incorporated into routine clinical practice, espe-
cially where BMD testing is unfeasible. A better under-
standing of which factors lead to an increase in the
incidence of fractures is a crucial step in evaluating
patients at risk and designing therapeutic strategies.
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